XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2021
Number of Shares      
Outstanding at beginning of period (in shares) 816,717    
Granted (in shares) 0 0  
Exercised (in shares) (35,625)    
Canceled (in shares) 0    
Outstanding at end of period (in shares) 781,092   816,717
Weighted-Average Exercise Price (in dollars per share)      
Outstanding at beginning of period (in dollars per share) $ 7.42    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 6.68    
Canceled (in dollars per share) 0    
Outstanding at end of period (in dollars per share) $ 7.49   $ 7.42
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Vested and Expected to Vest (in shares) 781,092    
Exercisable (in shares) 748,942    
Vested and Expected to Vest, Weighted Average Exercise Price (in dollars per share) $ 7.49    
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 7.42    
Outstanding, Weighted-Average Remaining Contractual Terms (in Years) 4 years 3 months 18 days   5 years 9 months 18 days
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (in Years) 4 years 3 months 18 days    
Exercisable, Weighted Average Remaining Contractual Term (in Years) 4 years 2 months 12 days    
Outstanding, Aggregate Intrinsic Value $ 1,505   $ 9,046
Vested and Expected to Vest, Aggregate Intrinsic Value 1,505    
Exercisable, Aggregate Intrinsic Value $ 1,505